A Phase III Study of PA21 in Hemodialysis Patients With Hyperphosphatemia
Clinical trial NCT01850602 · COMPLETED
Trial details
- NCT number
- NCT01850602
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-23
- Primary completion
- 2013-12-01
- Enrollment
- 213
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.